Broadleaf Partners’s Fidelity Blue Chip Growth ETF FBCG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.45M Buy
119,988
+2,683
+2% +$159K 1.44% 28
2026
Q1
$5.88M Sell
117,305
-4,486
-4% -$239K 1.37% 26
2025
Q4
$6.68M Buy
121,791
+476
+0.4% +$25.8K 1.41% 29
2025
Q3
$6.51M Sell
121,315
-15,092
-11% -$769K 1.36% 30
2025
Q2
$6.58M Buy
136,407
+17,648
+15% +$753K 1.45% 27
2025
Q1
$4.75M Sell
118,759
-3,660
-3% -$166K 1.24% 29
2024
Q4
$5.66M Buy
122,419
+4,026
+3% +$182K 1.32% 29
2024
Q3
$5.06M Buy
+118,393
New +$4.9M 1.2% 32

Other funds holding FBCG

Broadleaf Partners's FBCG Position: Q2 2026 in Review

Broadleaf Partners increased its Fidelity Blue Chip Growth ETF (FBCG) stake by 2.3% in Q2 2026, buying an estimated $159K and bringing the position to 119,988 shares worth $7.45M. The position accounts for 1.44% of the portfolio, ranked #28.

Broadleaf Partners first reported a position in FBCG in Q3 2024 and has held it in 8 quarters since. 317 funds tracked by Wall St. Rank hold FBCG as of Q2 2026.

  • Broadleaf Partners held 119,988 shares of Fidelity Blue Chip Growth ETF worth $7.45M as of Q2 2026.
  • Broadleaf Partners bought 2,683 Fidelity Blue Chip Growth ETF shares in Q2 2026, an estimated $159K.
  • Fidelity Blue Chip Growth ETF made up 1.44% of Broadleaf Partners's portfolio in Q2 2026, its #28 holding.
  • Broadleaf Partners first reported a position in Fidelity Blue Chip Growth ETF in Q3 2024 and has held it in 8 quarters since.
  • 317 funds tracked by Wall St. Rank held Fidelity Blue Chip Growth ETF as of Q2 2026.

Based on Broadleaf Partners's 13F filing for Q2 2026, filed 13 Aug 2026.